Listen to a podcast, please open Podcast Republic app. Available on Google Play Store and Apple App Store.
A podcast from Cencora where we discuss the latest industry information relevant to our GPO member practices. We will share regular updates from our knowledgeable staff and partners, as well as your respected peers, on everything from precision medicine and biosimilar innovations to practice management solutions and the legislative landscape. Listen from your computer during breaks at the office or from your phone on the go. OnCall will make it easy for you to access the education you want - whenever you want.
| Episode | Date |
|---|---|
|
Q1 2026 GPO Legislative Townhall
|
May 07, 2026 |
|
Operationalizing Radiopharmaceuticals in Your Practice
|
Apr 30, 2026 |
|
Radiopharmaceuticals: Billing and Reimbursement
|
Apr 23, 2026 |
|
Radiopharmaceutical Landscape
|
Mar 19, 2026 |
|
Introduction to Radiopharmaceuticals
|
Feb 16, 2026 |
|
Q4 2025 GPO Legislative Townhall
|
Jan 08, 2026 |
|
Q3 GPO Legislative Townhall
|
Oct 09, 2025 |
|
Inflation Reduction Act: Current State
|
Aug 14, 2025 |
|
Q2 GPO Legislative Townhall
|
Jul 31, 2025 |
|
Inflation Reduction Act: Overview
|
Jul 22, 2025 |
|
505(b)(2) Operationalizing in Practice - Provider Perspective
|
May 13, 2025 |
|
505(b)(2) Operationalizing in Practice - Pharmacist Perspective
|
May 01, 2025 |
|
505(b)(2) Billing and Reimbursement
|
Apr 17, 2025 |
|
505(b)(2) Landscape and Pipeline
|
Apr 03, 2025 |
|
505(b)(2) Basics
|
Mar 18, 2025 |
|
Buy and Bill: Practice Perspective
|
Feb 04, 2025 |
|
Buy and Bill: The Basics
|
Jan 22, 2025 |
|
GPO 101: Legislative Townhall
|
Jan 08, 2025 |
|
Biosimilar Basics: Payer Perspective
|
Jun 19, 2024 |
|
Biosimilar Basics: Legislation
|
May 23, 2024 |
|
Biosimilar Basics: Market Landscape
|
May 01, 2024 |
|
Biosimilar Basics: Overview
|
Apr 17, 2024 |
|
GPO Legislative Townhall December 2023: Part 11
|
Feb 08, 2024 |
|
GPO Legislative Townhall December 2023: Part 10
|
Feb 08, 2024 |
|
GPO Legislative Townhall December 2023: Part 9
|
Jan 11, 2024 |
|
GPO Legislative Townhall August 2023: Part 8
|
Nov 29, 2023 |
|
GPO Legislative Townhall August 2023: Part 7
|
Sep 07, 2023 |
|
GPO Legislative Townhall May 2023: Part 6
|
Aug 17, 2023 |
|
GPO Legislative Townhall May 2023: Part 5
|
Aug 01, 2023 |
|
GPO Legislative Townhall May 2023: Part 4
|
Jul 20, 2023 |
|
GPO Legislative Townhall Feb 2023: Part 3
|
Jul 06, 2023 |
|
GPO Legislative Townhall Feb 2023: Part 2
|
Jun 22, 2023 |
|
GPO Legislative Townhall Feb 2023: Part 1
|
Jun 07, 2023 |
|
Operational Pathways for Biomarker Testing in NSCLC
|
Mar 21, 2023 |
|
Biosimilar Series: Part 5
|
Sep 21, 2022 |
|
Biosimilar Series: Part 4
|
Sep 09, 2022 |
|
Biosimilar Series: Part 3
|
Aug 24, 2022 |
|
Biosimilar Series: Part 2
|
Jul 01, 2022 |
|
Biosimilar Series: Part 1
|
Jun 30, 2022 |
|
Biomarkers: Emerging Targets and Technologies
|
Mar 25, 2022 |
|
Biomarker Testing: A Closer Look at When, Who, and How to Test
|
Mar 11, 2022 |
|
Germline Genetic Testing
|
Mar 07, 2022 |
|
Buy and Bill 101: Part 4
|
Feb 16, 2022 |
|
Buy and Bill 101: Part 3
|
Feb 02, 2022 |
|
Biomarkers 101: Basics of Biomarker Testing
|
Jan 21, 2022 |
|
Buy and Bill 101: Part 2
|
Jan 19, 2022 |
|
Buy and Bill 101: Part 1
|
Jan 14, 2022 |
|
Novel Agents and Toxicity Management 101
|
Nov 08, 2021 |
|
Using AI Clinical Decision Support to Manage Cancer Complexity
|
Oct 25, 2021 |
|
Paradigms, Policy and Pharmacogenomics: What community oncologists need to know
|
Oct 11, 2021 |
|
Clinical trials: How has precision medicine elevated the role of community oncology?
|
Sep 03, 2021 |
|
Treating with TIBSOVO: A targeted therapeutic option for patients with R/R mIDH1 AML
|
Aug 03, 2021 |
|
Off Our Chests: A Discussion with Dr. John and Liza Marshall
|
Jul 08, 2021 |
|
Precision Medicine Series: Evolution Part 2
|
May 04, 2021 |
|
Precision Medicine Series: Evolution Part 1
|
Mar 09, 2021 |
|
A Conversation with Annexus Health
|
Mar 08, 2021 |
|
Precision Medicine Series: Precision Medicine Center
|
Dec 11, 2020 |